bell
The current prices are delayed by 15 mins, login to check live prices.
Thyrocare Technologies Ltd share price logo

Thyrocare Technologies Ltd

(THYROCARE)

₹956.15▲1.4%

as on 04:01PM, 22 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Thyrocare Technologies Ltd Analyst Rating

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts offering long term price targets for Thyrocare Technologies Ltd. An average target of ₹1007.5

Source: S&P Global Market Intelligence

Thyrocare Technologies Ltd Share analysis

Thyrocare Technologies Ltd price forecast by 2 analysts

Upside of5.37%

High

₹1040

Target

₹1007.50

Low

₹975

Thyrocare Technologies Ltd target price ₹1007.5, a slight upside of 5.37% compared to current price of ₹956.15. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Thyrocare Technologies Ltd Performance

  • Day's Low

    Day's High

    ₹939.8
    ₹978.7

  • 52 Week's Low

    52 Week's High

    ₹535.05
    ₹1,003.55
1 Month Return+ 5.24 %
3 Month Return+ 6.43 %
1 Year Return+ 73.7 %
Previous Close₹969.70
Open₹968.80
Volume84.87K
Upper Circuit-
Lower Circuit-
Market Cap₹5,136.73Cr

Thyrocare Technologies Ltd Key Statistics

P/E Ratio60.4
PEG Ratio16.82
Market Cap₹5,136.73 Cr
P/B Ratio6.54
EPS13.12
Dividend Yield3.04
SectorHealthcare
ROE13.75

Thyrocare Technologies Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd
BUY₹5,136.73 Cr14.21%0.54₹69 Cr₹571 Cr
Vijaya Diagnostic Centre Ltd
Vijaya Diagnostic Centre Ltd
BUY₹11,780.84 Cr19.34%0.64₹119 Cr₹547 Cr
Metropolis Healthcare Ltd
Metropolis Healthcare Ltd
HOLD₹10,334.21 Cr9.1%0.58₹128 Cr₹1,207 Cr
Dr Lal Pathlabs Ltd
Dr Lal Pathlabs Ltd
HOLD₹25,291.92 Cr19.32%0.55₹362 Cr₹2,226 Cr
Laurus Labs Ltd
Laurus Labs Ltd
HOLD₹26,372.98 Cr132.42%0.67₹168 Cr₹5,040 Cr
See all

Thyrocare Technologies Ltd Mutual Fund Holdings

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in 2000 and is one of the leading pan-India diagnostic chains, offering 636 distinct tests and 90 profiles of tests for early detection and management of various disorders and diseases. Additionally, they have set up Regional Processing Laboratories (RPLs) in 25 cities and Thryrocare International Holding Company (TIHC) in Mauritius has established a centre in Bahrain. In 2016, Thyrocare Technologies had a public offering that closed with an oversubscription of 75 times, and in 2018 acquired an Associate Company, Equinox Labs Private Limited, as well as bought back 958900 equity shares. In 2020, their services were negatively affected due to the Coronavirus, however, in 2021 they had a new promoter, Docon Technologies Private Limited, acquire 37656092 equity shares of the Company.As of March 31 2022, Thyrocare Technologies had a network of 1500 active channel partners and more than 9000 collection points spread across 500 districts in India and provided an extensive menu of over 700 tests, with more than 300 added within the year. Additionally, they installed automation for urine testing in 12 lab locations and Beckman Analysers in Zonal Processing Laboratories.

Share Price: ₹956.15 per share as on 22 Nov, 2024 04:01 PM
Market Capitalisation: ₹5,136.73Cr as of today
Revenue: ₹177.36Cr as on September 2024 (Q3 24)
Net Profit: ₹26.42Cr as on September 2024 (Q3 24)
Listing date: 09 May, 2016
Chairperson Name: Rahul Guha
OrganisationThyrocare Technologies Ltd
HeadquartersNavi Mumbai
IndustryHealthcare
E-voting on sharesClick here to vote

Key events for Thyrocare Technologies Ltd

  • Thyrocare Stock Shows Strong Upside Potential - 29 Oct, 2024

    Thyrocare Technologies stock, currently priced at Rs 949, has rallied 53% since July 2024. It has a potential upside to Rs 1,400, with key support and resistance levels identified.

  • Thyrocare Reports Strong Q2 Growth and Hits High - 24 Oct, 2024

    Thyrocare Technologies Ltd reported a 29% YoY profit increase to ₹26.4 crore and a 20% revenue rise to ₹177.4 crore for Q2 FY25. The stock reached a 52-week high, reflecting strong market performance and consistent revenue growth.

  • Thyrocare Technologies Reports Q2 Earnings Results - 23 Oct, 2024

    Thyrocare Technologies Limited announced its earnings results for the second quarter and six months ended September 30, 2024. The company operates in healthcare services, focusing on diagnostic testing and imaging services across India.

  • Thyrocare Completes Acquisition of Vimta Labs - 11 Oct, 2024

    Thyrocare Technologies Limited has successfully acquired the diagnostic and pathological services business of Vimta Labs Limited, effective October 11, 2024. This strategic move enhances Thyrocare's capabilities in the diagnostics industry.

Insights on Thyrocare Technologies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, THYROCARE stock has moved up by 52.0%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 12.84% to 12.90% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 15.35 Cr → 26.67 Cr (in ₹), with an average increase of 16.5% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 137.6 Cr → 179.97 Cr (in ₹), with an average increase of 8.4% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 11.50% to 12.16% in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 190.4% return, outperforming this stock by 203.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 71.11% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Fortis Healthcare Ltd has given 87.8% return, outperforming this stock by 14.1%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.49% to 1.93% in Sep 2024 quarter

Thyrocare Technologies Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹148.00Cr (-)₹134.74Cr (↓8.96%)₹154.25Cr (↑14.48%)₹156.91Cr (↑1.72%)₹177.36Cr (↑13.03%)
Net Income₹20.33Cr (-)₹14.74Cr (↓27.50%)₹17.18Cr (↑16.55%)₹23.94Cr (↑39.35%)₹26.42Cr (↑10.36%)
Net Profit Margin13.74% (-)10.94% (↓20.38%)11.14% (↑1.83%)15.26% (↑36.98%)14.90% (↓2.36%)
Value in ₹ crore
Details2021202220232024
Total Assets₹529.30Cr (-)₹597.65Cr (↑12.91%)₹612.62Cr (↑2.50%)₹621.41Cr (↑1.43%)
Total Liabilities₹83.84Cr (-)₹76.95Cr (↓8.22%)₹91.58Cr (↑19.01%)₹107.60Cr (↑17.49%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹136.33Cr (-)₹111.07Cr (↓18.53%)₹105.68Cr (↓4.85%)₹120.02Cr (↑13.57%)₹155.19Cr (↑29.30%)

Index Inclusions

BSE Healthcare

₹42,969.55

1.23 (▲522.48%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

BSE Small-Cap

₹52,612.93

0.9 (▲471.78%)

Thyrocare Technologies Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
71.11%
0.00
Foreign Institutions
1.93%
-22.69
Mutual Funds
12.9%
0.48
Retail Investors
12.16%
5.77
Others
1.9%
-7.75

Thyrocare Technologies Ltd Key Indicators

Details20202021202220232024
Return On Equity %24.8829.0831.4810.9413.75
Details20202021202220232024
Return On Assets %19.9421.3829.4710.5311.39
Details20202021202220232024
Book Value Per Share (₹)69.3980.8299.5497.3793.02
Details20202021202220232024
Earning Per Share (₹)16.7321.433.312.1613.12

Thyrocare Technologies Ltd Valuation

Thyrocare Technologies Ltd in the last 5 years

  • Overview

  • Trends

Lowest (18.71x)

June 23, 2022

Today (60.40x)

November 22, 2024

Industry (97.12x)

November 22, 2024

Highest (91.79x)

October 27, 2020

LowHigh

Thyrocare Technologies Ltd Earnings and Dividends

  • Thyrocare Technologies Ltd Earnings Results

    Thyrocare Technologies Ltd’s net profit jumped 31.12% since last year same period to ₹26.67Cr in the Q2 2024-2025. On a quarterly growth basis, Thyrocare Technologies Ltd has generated 10.34% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Thyrocare Technologies Ltd Dividends May,2024

    In the quarter ending March 2024, Thyrocare Technologies Ltd has declared dividend of ₹18 - translating a dividend yield of 1.88%.

    Read More about Dividends

Thyrocare Technologies Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Thyrocare Technologies Ltd is currently in a Bullish trading position according to technical analysis indicators.

More on Technical Analysis

FAQs on Thyrocare Technologies Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Thyrocare Technologies Ltd shares.

Thyrocare Technologies Ltd (THYROCARE) share price today is ₹956.15

Thyrocare Technologies Ltd is listed on NSE

Thyrocare Technologies Ltd is listed on BSE

  • Today’s highest price of Thyrocare Technologies Ltd is ₹978.7.
  • Today’s lowest price of Thyrocare Technologies Ltd is ₹939.8.

PE Ratio of Thyrocare Technologies Ltd is 60.4

PE ratio = Thyrocare Technologies Ltd Market price per share / Thyrocare Technologies Ltd Earnings per share

Today’s traded volume of Thyrocare Technologies Ltd(THYROCARE) is 84.87K.

Today’s market capitalisation of Thyrocare Technologies Ltd(THYROCARE) is ₹5136.73Cr.

Thyrocare Technologies Ltd(THYROCAREPrice
52 Week High
₹1003.55
52 Week Low
₹535.05

Thyrocare Technologies Ltd(THYROCARE) share price is ₹956.15. It is down -4.72% from its 52 Week High price of ₹1003.55

Thyrocare Technologies Ltd(THYROCARE) share price is ₹956.15. It is up 78.70% from its 52 Week Low price of ₹535.05

Thyrocare Technologies Ltd(THYROCAREReturns
1 Day Returns
-13.55%
1 Month Returns
5.24%
3 Month Returns
6.43%
1 Year Returns
73.7%